Olyset Plus

Further information coming soon.

Research & Reports

A cluster randomized controlled trial by Nagasaki University on Olyset Plus LN, a long-lasting net incorporating the synergist Piperonyl Butoxide (PBO), resulting in reduced risk of malaria in children in Western Kenya in an area where mosquito vectors with metabolic resistance predominate, causing high levels of pyrethroid resistance.

Download Full Report

PDF Downloads

Technical BrochureEnglishDownload PDF